experience for a full-time, office-based AssociateClinical Trial Manager (aCTM) to join our France, Lyon Clinical Trial... not required but will be advantageous Medpace Overview : Medpace is a full-service clinical contract research organization (CRO). We provide Phase I-IV...
experience for a full-time, office-based AssociateClinical Trial Manager (aCTM) to join our France, Lyon Clinical Trial... not required but will be advantageous Medpace Overview : Medpace is a full-service clinical contract research organization (CRO). We provide Phase I-IV...
Research experience for a full-time, office-based AssociateClinical Trial Manager (aCTM) to join our France, Lyon Clinical... industry not required but will be advantageous Medpace Overview Medpace is a full-service clinical contract research...
Research experience for a full-time, office-based AssociateClinical Trial Manager (aCTM) to join our France, Lyon Clinical... industry not required but will be advantageous Medpace Overview Medpace is a full-service clinical contract research...
for a full-time, office-based AssociateClinical Trial Manager (aCTM) to join our France, Lyon Clinical Trial Management team... not required but will be advantageous Medpace Overview Medpace is a full-service clinical contract research organization (CRO). We provide Phase I-IV...
experience for a full-time, office-based AssociateClinical Trial Manager (aCTM) to join our France, Lyon Clinical Trial... industry not required but will be advantageous Medpace Overview Medpace is a full-service clinical contract research...
experience for a full-time, office-based AssociateClinical Trial Manager (aCTM) to join our France, Lyon Clinical Trial... industry not required but will be advantageous Medpace Overview Medpace is a full-service clinical contract research...
Overview ICON plc is a world-leading healthcare intelligence and clinicalresearch organisation. From molecule... to medicine, we advance clinicalresearch providing outsourced services to pharmaceutical, biotechnology, medical device...
in Paris. Essential Functions Complete appropriate therapeutic, protocol and clinicalresearch training to perform.... Knowledge of applicable clinicalresearch regulatory requirements, i.e., Good Clinical Practice (GCP) and International...
#CRASDAJD IQVIA is a leading global provider of clinicalresearch services, commercial insights and healthcare intelligence...IQVIA Clinical Functional Services Partnerships (FSP) business is unique. Our teams are dedicated to a single sponsor...
As the year 2024 is nearing its end, investors will be hoping for Santa Claus rally. This phenomenon occurs when stocks rise on the last five trading sessions of December and the first two trading sessions of January Continue Reading »
Transrail Lighting IPO: The public issue is poised to witness its final day of public bidding on Monday, December 23. The IPO has been subscribed 5.31x the shares available as of Day 2. Check details on whether to apply or not? Continue Reading »
What do you think was the top performing asset of 2024? Some microcap stock? Bitcoin? Real estate? It was actually Diljit Dosanjh’s pan-India concert tickets. This analysis will surprise you. Continue Reading »
Senores Pharma IPO Apply or not: The Senores Pharmaceuticals' public issue will close for public bidding on December 24. The IPO has received 1.78x subscription on Day 1, as of last week Friday. Continue Reading »
Unimech Aerospace IPO price band is set at ₹745 to ₹785 per share and the IPO lot size is 19 shares. The company plans to raise ₹500 crore at the upper-end of the price band of the book built issue which is a combination of fresh issue and OFS worth ₹250 crore each. Continue Reading »
DAM Capital Advisors IPO price band is set at ₹269 to ₹283 per share. The ₹840.25-crore worth DAM Capital Advisors IPO is entirely an offer for sale (OFS) of 2.97 crore shares. Continue Reading »
Mamata Machinery IPO price band was set at ₹230 to ₹243 per share. The company aims to raise ₹179.39 crore from the book-built issue which is entirely an offer for sale of 73.82 lakh shares. Continue Reading »